Billing and
Diagnosis Codes

Advanced Renal Cell Carcinoma (aRCC) Combination Therapy

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

BMS Access Support provides coding and distribution information for only Bristol Myers Squibb products.

Reimbursement and Coding Guide for OPDIVO
Download

Codes*
Distribution
FDA Letters

Filter by keyword Clear Filter

Type a keyword to find a specific HCPCS, CPT, NDC, or ICD-10 code

Healthcare Common Procedure Coding System (HCPCS) Codes¹ Issued by CMS

OPDIVO

J9299

COPY

Injection, nivolumab, 1 mg

Providers and suppliers are required to report the JW modifier on Part B drug claims for discarded drugs and biologicals. Also, providers and suppliers must document the amount of discarded drugs or biologicals in Medicare beneficiaries’ medical records.²

YERVOY^® (ipilimumab)

J9228

COPY

Injection, ipilimumab, 1 mg

Revenue Codes (for Use in the Hospital Outpatient Setting)³

0636

Drugs requiring detailed coding

0335

Chemotherapy administration, IV

0260

IV Therapy-General

Current Procedural Terminology (CPT)^4,†

OPDIVO

96413

COPY

Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

YERVOY

96417

COPY

Chemotherapy administration, IV infusion; each additional sequential infusion (different substance/drug), up to 1 hour (list separately in addition to code for primary procedure). (Use 96417 in conjunction with 96413)

96415

COPY

Chemotherapy administration, IV infusion; each additional hour (list separately in addition to code for primary procedure). (Report 96415 for infusion intervals of greater than 30 minutes beyond 1-hour increments)

National Drug Codes (NDC)^5,6 Issued by the FDA

Note:Payers require the submission of the 11-digit NDC on healthcare claim forms. Please use the 11-digit codes shown here.

OPDIVO

00003-3772-11

COPY

40 mg/4 mL (10 mg/mL) single-dose vial

00003-3774-12

COPY

100 mg/10 mL (10 mg/mL) single-dose vial

00003-3756-14

COPY

120 mg/12 mL (10 mg/mL) single-dose vial

00003-3734-13

COPY

240 mg/24 mL (10 mg/mL) single-dose vial

YERVOY

00003-2327-11

COPY

One 50-mg vial (5 mg/mL), single-dose vial

00003-2328-22

COPY

One 200-mg vial (5 mg/mL), single-dose vial

International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)⁷

C64

COPY

Malignant neoplasm of kidney, except renal pelvis

C64.1

Malignant neoplasm of right kidney, except renal pelvis

C64.2

COPY

Malignant neoplasm of left kidney, except renal pelvis

C64.9

COPY

Malignant neoplasm of unspecified kidney, except renal pelvis

C65

COPY

Malignant neoplasm of renal pelvis

C65.1

COPY

Malignant neoplasm of right renal pelvis

C65.2

COPY

Malignant neoplasm of left renal pelvis

C65.9

COPY

Malignant neoplasm of unspecified renal pelvis

Z51.12

COPY

Encounter for antineoplastic immunotherapy

If infusion for antineoplastic immunotherapy is the only reason for the patient encounter, physicians and hospitals may report ICD-10-CM code “Z51.12 Encounter for antineoplastic immunotherapy” as the primary diagnosis.

OPDIVO and YERVOY^® (ipilimumab) may be purchased through the distributors listed below.

Physician Offices

Specialty Distributor	Phone Orders	Fax Orders and Website
Besse Medical	1-888-711-5469 Monday-Friday, 7 AM-11 PM ET	https://www.besse .com
Cardinal Health Specialty Pharmaceutical Distribution	1-877-453-3972 Monday-Friday, 7 AM-6 PM CT (24-hour emergency on call)	https://specialty online.cardinal health.com
CuraScript Specialty Distribution	1-877-599-7748 Monday-Friday, 8 AM-7 PM ET	https://www. curascriptsd. com
McKesson Specialty Health	1-800-482-6700 Monday-Friday, 7 AM-7 PM CT	https://mscs. mckesson.com
Morris & Dickson Specialty	1-800-710-6100 Monday-Friday, 8 AM-6 PM CT	Fax: 1-318-524-3096 https://www. mdspecialtydist. com
Oncology Supply	1-800-633-7555 Monday-Friday, 8 AM-7 PM CT	https://www. oncologysupply. com

For offices that prefer to use the services of a specialty pharmacy, specialty pharmacies can obtain OPDIVO and YERVOY from the distributors listed above.

Hospitals and Infusion Centers

Specialty Distributor	Phone Orders	Fax Orders and Website
ASD Healthcare	1-800-746-6273 Monday-Thursday, 7 AM-6:30 PM CT; Friday, 7 AM-6 PM CT	Fax: 1-800-547-9413 https://www. asdhealthcare. com
Cardinal Health Specialty Pharmaceutical Distribution	1-866-677-4844 Monday-Friday, 7 AM-6 PM CT (24-hour emergency on call)	Fax: 1-614-553-6301 https://order express.cardinal health.com
DMS Pharmaceutical Group, Inc.	1-877-788-1100 Monday-Friday, 8:30 AM-5 PM CT	Fax: 1-847-518-1105 www.dms pharma.com
McKesson Plasma and Biologics	1-877-625-2566 Monday-Friday, 8 AM-6:30 PM CT	Fax: 1-888-752-7626 https://connect. mckesson.com
Morris & Dickson Specialty	1-800-710-6100	Fax: 1-318-524-3096 https://www.mdspecialtydist.com

Puerto Rico Hospitals and Clinics

Authorized Distributor	Phone Orders	Fax Orders and Website
AmerisourceBergen Puerto Rico	1-844-222-2273	https://abcorder.amerisourcebergen.com

Above information is accurate as of 11/21.

The OPDIVO and YERVOY distribution program includes extended payment terms to Bristol Myers Squibb authorized OPDIVO and YERVOY distributors. Healthcare providers and institutions should contact their OPDIVO and YERVOY distributor to understand specific payment terms that may be available to them from their distributor.

Please see U.S. Full Prescribing Information for OPDIVO and YERVOY.

FDA Approval Letters as Posted by the FDA:

OPDIVO in combination with YERVOY^® (ipilimumab) for the first-line treatment of patients with intermediate or poor risk, advanced RCC – Approved on 04/16/2018

View Letter

OPDIVO in combination with cabozantinib for the first-line treatment of patients with advanced renal cell carcinoma (RCC) – Approved on 01/22/2021

View Letter

Availability of OPDIVO 120 mg vial – Approved on 08/27/2021

View Letter

Please see U.S. Full Prescribing Information for OPDIVO and YERVOY for complete indications.

Coding for OPDIVO and YERVOY is dependent on the insurer and the care setting in which the drug will be administered. Oncology practices need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer requirements.

Please see U.S. Full Prescribing Information for OPDIVO and YERVOY.

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient's medical record, the coding requirements of each health insurer, and best coding practices. Coding information provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards. All of the coding information presented by this website is applicable to outpatient procedures only.

†CPT codes and descriptions only are ©2019 by American Medical Association (AMA). All rights reserved. The AMA assumes no liability for data contained or not contained herein. CPT is a registered trademark of the American Medical Association.

References:

American Medical Association. 2020 HCPCS Level II. Professional ed. Chicago, IL: American Medical Association; 2020.
Centers for Medicare & Medicaid Services. MLN Matters, Number MM9603 Revised. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9603.pdf. Revised June 10, 2016. Accessed November 15, 2019.
Palmetto GBA. Medicare Part A Billing Guide. May 2017. http://www.palmettogba.com/Palmetto/Providers.Nsf/files/ Part_A_Billing_Guide.pdf/$File/Part_A_Billing_Guide.pdf. Accessed October 10, 2019.
American Medical Association. CPT Professional 2020. Professional ed. Chicago, IL: American Medical Association; 2019.
OPDIVO [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
YERVOY [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
Centers for Medicare & Medicaid Services. ICD-10-CM tabular list of diseases and injuries. https://www.cms.gov/Medicare/Coding/ICD10/2020-ICD-10-CM. Accessed September 1, 2021.

OPDIVO^® (nivolumab)

Charitable Foundations
Resource

Billing and
Diagnosis Codes

Physician Offices

Hospitals and Infusion Centers

Puerto Rico Hospitals and Clinics

Billing and Diagnosis Codes

Physician Offices

Hospitals and Infusion Centers

Puerto Rico Hospitals and Clinics

I verify that I am a

I am a

Billing and
Diagnosis Codes